FSRH statement on the interim decision by the Joint Committee on Vaccination and Immunisation (JCVI) to deny the Human Papilloma Virus (HPV) vaccination to boys
File size 350KB | Date: 19 July 2017
FSRH press statement: interim decision by the Joint Committee on Vaccination and Immunisation (JCVI) to deny the Human Papilloma Virus (HPV) vaccination to boys
Posted 19 July 2017
Date: 19 Jul 2017
Type: FSRH Press Releases and Statements
FSRH would like to express its concern over the interim recommendation by the JCVI, the government’s vaccination advisory body, to not provide the Human Papilloma Virus (HPV) vaccination to all boys.
Dr Asha Kasliwal, FSRH President, said:
“The interim decision to deny boys the HPV vaccination is a huge missed opportunity for improving long-term SRH outcomes and tackling gender inequality. FSRH aims to improve women’s sexual and reproductive health, especially access to contraception. However, HPV affects not only women, but also men, and FSRH firmly believes that men and boys are vital in contributing to secure women’s reproductive health and rights. We support boys and men’s right to access high-quality SRH services and live a life free of sexually-transmitted infections such as HPV. FSRH calls on JCVI to reverse its decision when it convenes in October.”
Download the full statement below
Related Documents